Bryn Mawr Trust CO United Therapeutics Corp Transaction History
Bryn Mawr Trust CO
- $5.88 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in United Therapeutics Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 88 shares of UTHR stock, worth $39,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88
Previous 39
125.64%
Holding current value
$39,197
Previous $11,000
227.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
751Shares Held
43.4MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.98 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.06 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$965 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$944 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $20.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...